Somebody do me a favor-- take a look at CARR. Now I'm no expert but I employ uptrend analysis like this... I use the edge of a Raw rolling paper pack, it's the perfect size for a lap top screen and I put up a chart of a stock like CARR and I look at six months or so and I take that rolling papers edge flap and I put it on the angle up from the first move up and the prior peaks, touching all the peaks and it kind of points at a number on the right- in this case $28.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Ideas For Now-
- Thread starter stonedinvestor
- Start date
And one last thing... this is to my wife mainly I may of lost the argument about whether lack of air conditioning constitutes an emergency within the CT state police & Rescue system. Ok that snarky phone operator had one up on me. Fine. Nobody ever called back.
However- I will not accept that this is a ' white person problem ' as my wife has said a few times. This is incorrect.
However- I will not accept that this is a ' white person problem ' as my wife has said a few times. This is incorrect.
Ok Stoney... I'm gonna give your hvac a a few seconds here.Day Two Without Air Conditioning. Sunday. No Van they won't come. It's not an " emergency " Yesterday was spent defining ' emergency ' The folks that fix the old boiler downstairs they service the air con I'm pretty sure because the air con comes through the boilers ducts in a limited way and wafts through the house. Well they say it's not an emergency. And I say in the winter when I say I have no heat... (this has happened a few times) It is an emergency why then in the summer when I say no air conditioning is it not? Makes no sense!
Now I have to wait for a phone cal back Monday and god knows when they'll get here and YUP HEAT WAVE three consecutive days of 90 + are on the way! Great. And the weatherman says high humidity to boot-- he actually said you are going to want to keep on your air conditioning.
It's a large Carrier unit... oh please just let it be a little repair... Why won't the fan turn?
Which fan is not turning? The air handler inside or the condensing unit outside?
My second question is... I'm not understanding this whole boiler thing. Those typically move hot water throughout a structure and the heat exchange occurs via a radiator... be it conductive or convective. You're not moving cold water through those pipes unless its a high-rise office building or condo with a chilling tower on top.
Sooo... to better understand your problem.... is your AC a forced air operation? This means is there duct-work, an air handling unit with a fan and an A-Coil on top, and copper tubing going outside to a condensing unit?
The number one question right now however is which fan is not working? Outside or inside?
Last edited:
Van thank you so much no one else will help me. You do not have to wear a mask. Ok it's the outside fan. No turn. Not electrical because I flipped the breaker and a small unit I have for the third floor is still working.
The inside fan I can hear that's actually part of the boiler system. So what happens is the cool air is forced up the same dirty ducts that the hot air is. So yes I believe it is a forced air set up.
Why would the outside fan stop turning? This is really getting dangerous.
DAY 3-- Sleep not so much. Tiny upstairs bed shared with 16 year old huge son. Have bruises on right side. Wife stayed with dog in the suffering heat. She's not so happy this morning. Just like I predicted my " white person " problem has become her problem.
I NEED HELP NOW! It's an e-m-e-r-g-e-n-c-y. I have a stuffed left ear and this is making it worse.
PLEASE-! Day after day so hot. I have to water a whole s load of plants do you now how hard that is in the heat? Yes I can jump in my pool.. well no I can't jump in I can't put my head under water because of this stuffed ear. Usually i go to the Dr and they blow it out with a syringe this time because of Covid I sent away for a CVS ear flusher... oh it looks deadly! I think it may actually work but I'm afraid to try. Reading the testimonials a lot of guys seem to say it worked on plunge #30. 30? It usually takes one to three or four at the Dr.. and that leaves you head spinning, brains scrambled and unable to drive.. thirty plunges?
You can see I have quite the day ahead of me.
Ok I woke up this morning and it hit me like a ton of bricks. - The Gilliad story is not broken.
I think GILD may be an important part of the portfolio. This Covid thing it's lurking, it's one of the most confusing virus's ever-- 17 players on a college football team get it and not a one is sick. They all feel fine! You can't ask all of them to take 14 days off... This contact tracing needs to change a bit people that have it need to have their cellphones put off a warning of some sort that other phones can pick up and basically in a big game of where's waldo... you walk down the street and if you have diabetes or are old you listen for your cell phone to warn you and then like avoiding zombies you run. That's the only way out of this mess.
Ok I read a blurb that India has ok'd Generic GILD drug this is a slight concern why don't they still have the international rights.. but we know GILD is well positioned here in the states...
I don't know why-- first thing in my head is GILD.
The inside fan I can hear that's actually part of the boiler system. So what happens is the cool air is forced up the same dirty ducts that the hot air is. So yes I believe it is a forced air set up.
Why would the outside fan stop turning? This is really getting dangerous.
DAY 3-- Sleep not so much. Tiny upstairs bed shared with 16 year old huge son. Have bruises on right side. Wife stayed with dog in the suffering heat. She's not so happy this morning. Just like I predicted my " white person " problem has become her problem.
I NEED HELP NOW! It's an e-m-e-r-g-e-n-c-y. I have a stuffed left ear and this is making it worse.
PLEASE-! Day after day so hot. I have to water a whole s load of plants do you now how hard that is in the heat? Yes I can jump in my pool.. well no I can't jump in I can't put my head under water because of this stuffed ear. Usually i go to the Dr and they blow it out with a syringe this time because of Covid I sent away for a CVS ear flusher... oh it looks deadly! I think it may actually work but I'm afraid to try. Reading the testimonials a lot of guys seem to say it worked on plunge #30. 30? It usually takes one to three or four at the Dr.. and that leaves you head spinning, brains scrambled and unable to drive.. thirty plunges?
You can see I have quite the day ahead of me.
Ok I woke up this morning and it hit me like a ton of bricks. - The Gilliad story is not broken.
I think GILD may be an important part of the portfolio. This Covid thing it's lurking, it's one of the most confusing virus's ever-- 17 players on a college football team get it and not a one is sick. They all feel fine! You can't ask all of them to take 14 days off... This contact tracing needs to change a bit people that have it need to have their cellphones put off a warning of some sort that other phones can pick up and basically in a big game of where's waldo... you walk down the street and if you have diabetes or are old you listen for your cell phone to warn you and then like avoiding zombies you run. That's the only way out of this mess.
Ok I read a blurb that India has ok'd Generic GILD drug this is a slight concern why don't they still have the international rights.. but we know GILD is well positioned here in the states...
I don't know why-- first thing in my head is GILD.
La Jolla Pharma makes unsolicited bid for Tetraphase Pharma
Jun. 22, 2020 6:33 AM ET|About: Tetraphase Pharmaceuti... (TTPH)|
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ:TTPH) is not over yet. La Jolla Pharmaceutical (NASDAQ:LJPC) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs).
The board has determined that the offer is superior to Melinta Therapeutics' (NASDAQ:MLNT) bid of $39.0M in cash plus $16.0M payable under CVRs. Under the terms of their merger agreement, it has notified Melinta that it is considering changing its recommendation to the La Jolla bid or terminating the merger agreement unless it submits a revised offer on or prior to Friday, June 26.
Earlier, Melinta outbid AcelRx Pharmaceuticals (NASDAQ:ACRX) for the company.
TTPH is up 29% premarket on light volume./////
La Jolla is one of our baby bios what are they up to?
Jun. 22, 2020 6:33 AM ET|About: Tetraphase Pharmaceuti... (TTPH)|
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ:TTPH) is not over yet. La Jolla Pharmaceutical (NASDAQ:LJPC) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs).
The board has determined that the offer is superior to Melinta Therapeutics' (NASDAQ:MLNT) bid of $39.0M in cash plus $16.0M payable under CVRs. Under the terms of their merger agreement, it has notified Melinta that it is considering changing its recommendation to the La Jolla bid or terminating the merger agreement unless it submits a revised offer on or prior to Friday, June 26.
Earlier, Melinta outbid AcelRx Pharmaceuticals (NASDAQ:ACRX) for the company.
TTPH is up 29% premarket on light volume./////
La Jolla is one of our baby bios what are they up to?
Remdesivir OK'd in India at $39-52 per dose
Jun. 21, 2020 4:56 PM ET|About: Gilead Sciences, Inc. (GILD)|B
India's Controller General has approved generic versions of Gilead Sciences' (NASDAQ:GILD) remdesivir for the treatment of COVID-19.
Two domestic drugmakers, Hyderabad-based Hetero and Mumbai-based Cipla, plan to launch their offerings within a week at Rs 5,000-6,000 ($65-78) and Rs 3,000-4,000 ($39-52), respectively.
According to current Indian government guidelines, a COVID-19 patient may need five-to-six doses, implying a total treatment cost of the antiviral as low as $195.
Gilead has yet to announce the price in the U.S. but it's safe to say it will be substantially higher. Drug cost watchdog ICER issued a report last month that the medicine would be cost-effective at $4,500 per course of treatment.
Jun. 21, 2020 4:56 PM ET|About: Gilead Sciences, Inc. (GILD)|B
India's Controller General has approved generic versions of Gilead Sciences' (NASDAQ:GILD) remdesivir for the treatment of COVID-19.
Two domestic drugmakers, Hyderabad-based Hetero and Mumbai-based Cipla, plan to launch their offerings within a week at Rs 5,000-6,000 ($65-78) and Rs 3,000-4,000 ($39-52), respectively.
According to current Indian government guidelines, a COVID-19 patient may need five-to-six doses, implying a total treatment cost of the antiviral as low as $195.
Gilead has yet to announce the price in the U.S. but it's safe to say it will be substantially higher. Drug cost watchdog ICER issued a report last month that the medicine would be cost-effective at $4,500 per course of treatment.
It appears that GILD licensed the drug to India through Dr Reddy an old friend. (My Mom loved Dr Reddy stock) Ok so revenue should come in for that and I see Singapore has started using the drug.. so world wide use and now GILD is heading into their own phase 2-3 testing. Why the delay? It's already being used elsewhere... Do we get in ahead of what we know has to be limited good news....?
In other COvid newsFollowing the regulatory nod, Mumbai-based Glenmark Pharmaceuticals (OTC:GLKQY) has launched antiviral favipiravir in India for the treatment of patients with mild-to-moderate COVID-19.
The company markets the oral pyrazinecarboxamide derivative, which works by inhibiting an enzyme called RNA polymerase, under the brand name FabiFlu for the treatment of influenza.
The company says the drug will be available as a 200 mg tablet at a maximum retail price of Rs 3,500 per strip of 34 (Rs 103/tablet) ($1.34/tablet).
It is marketed in Japan for the flu under the brand name Avigan by Fujifilm Holdings unit Fujifilm Toyama Chemical but it is being tested for COVID-19 in over 40 countries. Prime Minister Shinzo Abe is pushing for fast track approval in Japan for mild-to-moderately ill patients.
--> So this is the Japan wonder drug that we have been hearing about.-- $1.34 a tablet this is an extreme low amount and will provide major headwinds for GILD or will it?
<$39- $52 a dose in India..... much more in America... Vs Japan $1.34......
In other COvid newsFollowing the regulatory nod, Mumbai-based Glenmark Pharmaceuticals (OTC:GLKQY) has launched antiviral favipiravir in India for the treatment of patients with mild-to-moderate COVID-19.
The company markets the oral pyrazinecarboxamide derivative, which works by inhibiting an enzyme called RNA polymerase, under the brand name FabiFlu for the treatment of influenza.
The company says the drug will be available as a 200 mg tablet at a maximum retail price of Rs 3,500 per strip of 34 (Rs 103/tablet) ($1.34/tablet).
It is marketed in Japan for the flu under the brand name Avigan by Fujifilm Holdings unit Fujifilm Toyama Chemical but it is being tested for COVID-19 in over 40 countries. Prime Minister Shinzo Abe is pushing for fast track approval in Japan for mild-to-moderately ill patients.
--> So this is the Japan wonder drug that we have been hearing about.-- $1.34 a tablet this is an extreme low amount and will provide major headwinds for GILD or will it?
<$39- $52 a dose in India..... much more in America... Vs Japan $1.34......
Last Wed Press Release)
Gilead to enroll pediatric patients for new remdesivir study soon, Reuters says 16:58 GILD Gilead Sciences said it will soon initiate enrollment of pediatric patients with moderate-to-severe COVID-19 in a late-stage clinical trial testing remdesivir, Reuters' Trisha Roy reports. The trial will evaluate the efficacy and safety of the treatment in the patients, which would include newborns to adolescents, across over 30 sites in the U.S. and Europe.
Gilead to enroll pediatric patients for new remdesivir study soon, Reuters says 16:58 GILD Gilead Sciences said it will soon initiate enrollment of pediatric patients with moderate-to-severe COVID-19 in a late-stage clinical trial testing remdesivir, Reuters' Trisha Roy reports. The trial will evaluate the efficacy and safety of the treatment in the patients, which would include newborns to adolescents, across over 30 sites in the U.S. and Europe.
Turn your thermostat way down with the AC selected, ie like you would if everything was working and you wanted to cool the house down.Van thank you so much no one else will help me. You do not have to wear a mask. Ok it's the outside fan. No turn. Not electrical because I flipped the breaker and a small unit I have for the third floor is still working.
The inside fan I can hear that's actually part of the boiler system. So what happens is the cool air is forced up the same dirty ducts that the hot air is. So yes I believe it is a forced air set up.
Why would the outside fan stop turning? This is really getting dangerous.
.
Now, you said you can hear the inside fan so I'm assuming you are getting air moving through your (lol) dirty ducts.
Go outside to the condenser, and see if you can hear a buzzing sound. Even though the fan is not moving.
Now Italy joins the party!!! They are using the same Indian supply..... What does this al mean for GILD -- Oh my-- look at the end of the day Friday... Please do an hourly and look at the end of the day fri day for GILD. A huge spike in the last few minutes someone waited all day for that entry on a sleepy Friday...
Shares in Gilead rose 4.6% to $77.47 on Friday taking the year-to-date advance to 19%.
That advance came in the waning minutes of trading<----
Gilead’s $1 billion investment in remdesivir manufacturing, R&D and sales and marketing efforts are potentially not reflected in 2Q/3Q20 consensus earnings estimates, which could potentially lead to earnings misses.<-- DANGER DANGER****
Do we want to be in now & then out before earnings?
Shares in Gilead rose 4.6% to $77.47 on Friday taking the year-to-date advance to 19%.
That advance came in the waning minutes of trading<----
Gilead’s $1 billion investment in remdesivir manufacturing, R&D and sales and marketing efforts are potentially not reflected in 2Q/3Q20 consensus earnings estimates, which could potentially lead to earnings misses.<-- DANGER DANGER****
Do we want to be in now & then out before earnings?